Page last updated: 2024-11-02

pamidronate and Sclerosis

pamidronate has been researched along with Sclerosis in 8 studies

Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.

Research Excerpts

ExcerptRelevanceReference
"Pamidronate disodium is a second-generation biphosphonate, a group of compounds that are being used increasingly to inhibit bone resorption in disorders that are characterized by excessive bone loss such, as hypercalcemia of malignancy, osteoporosis, and Paget's disease."5.29Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site. ( Ford, JM; Fuji, T; Fushimi, H; Tanaka, M, 1996)
"Pamidronate was administered intravenously up to four times a year."1.37Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. ( de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP, 2011)
"Pamidronate disodium is a second-generation biphosphonate, a group of compounds that are being used increasingly to inhibit bone resorption in disorders that are characterized by excessive bone loss such, as hypercalcemia of malignancy, osteoporosis, and Paget's disease."1.29Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site. ( Ford, JM; Fuji, T; Fushimi, H; Tanaka, M, 1996)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goyal, P1
Gupta, S1
Kuijpers, SC1
de Jong, E1
Hamdy, NA1
van Merkesteyn, JP1
Urade, M1
Noguchi, K1
Takaoka, K1
Moridera, K1
Kishimoto, H1
Sugata, T1
Fujita, Y1
Myoken, Y1
Kiriyama, T1
Damiani, D1
Tanaka, M1
Fushimi, H1
Fuji, T1
Ford, JM1
Ripamonti, C1
Fulfaro, F1
Polastri, D1
De Conno, F1
Laffranchi, A1
Moliterni, A1
Morton, AR1
Cantrill, JA1
Pillai, GV1
McMahon, A1
Anderson, DC1
Howell, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420]Phase 14 participants (Actual)Interventional2005-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

8 other studies available for pamidronate and Sclerosis

ArticleYear
Young Female With Pain in the Left Leg.
    Annals of emergency medicine, 2019, Volume: 74, Issue:4

    Topics: Accidental Falls; Bone Density Conservation Agents; Child; Female; Femur; Fibula; Humans; Leg; Leg B

2019
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2011, Volume: 39, Issue:1

    Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up

2011
Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2012, Volume: 114, Issue:4

    Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Mandibular Diseases; Middle Aged;

2012
Successful management of severe facial pain in patients with diffuse sclerosing osteomyelitis (DSO) of the mandible using disodium clodronate.
    International journal of oral and maxillofacial surgery, 2003, Volume: 32, Issue:5

    Topics: Anti-Inflammatory Agents; Diphosphonates; Facial Pain; Female; Humans; Mandibular Diseases; Middle A

2003
Metaphyseal sclerosis associated with bisphosphonate therapy.
    Journal of pediatric endocrinology & metabolism : JPEM, 2007, Volume: 20, Issue:11

    Topics: Alendronate; Bone and Bones; Bone Density Conservation Agents; Dermatomyositis; Diphosphonates; Huma

2007
Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site.
    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 1996, Volume: 5, Issue:3

    Topics: Adenocarcinoma; Cervical Vertebrae; Diphosphonates; Female; Humans; Middle Aged; Neoplasms, Unknown

1996
Pain relief and sclerosis of bone metastases in a patient with breast cancer treated with tamoxifen, radiotherapy and pamidronate disodium: which treatment helped?
    Journal of pain and symptom management, 1998, Volume: 16, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Mod

1998
Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
    BMJ (Clinical research ed.), 1988, Sep-24, Volume: 297, Issue:6651

    Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Humans; Infusions, Intravenous; Os

1988